Portal de investigação
The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI Perspective
Data de publicação:
Data Ahead of Print:
Autores da FMUP
Participantes de fora da FMUP
- Bousquet, J
- Jutel, M
- Pfaar, O
- Agache, I
- Czarlewski, W
- Bachert, C
- Bergmann, KC
- Cruz, AA
- Klimek, L
- Kvedariene, V
- Larenas Linnemann, DE
- Papadopoulos, NG
- Patella, V
- Regateiro, FS
- Scichilone, N
- Shamji, MH
- Sheikh, A
- Valovirta, E
- Ventura, MT
- Zuberbier, T
Unidades de investigação
Abstract
Allergen immunotherapy (AIT) is a proven therapeutic option for the treatment of allergic rhinitis and/or asthma. Many international or national practice guidelines have been produced, but the evidence-based method varies and they do not usually propose care pathways. The present article considers the possible role of mobile health in AIT for allergic rhinitis/asthma. There are no currently available validated biologic biomarkers that can predict AIT success, and mobile health biomarkers have some relevance. In the current article, the following aspects will be discussed: patient stratification for AIT, symptom-medication scores for the follow-up of patients, clinical trials, as well as the approach of the European Academy of Allergy and Clinical Immunology. (C) 2021 American Academy of Allergy, Asthma & Immunology
Copyright © 2021 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Dados da publicação
- ISSN/ISSNe:
- 2213-2198, 2213-2201
- Tipo:
- Review
- Páginas:
- 1805-1812
- Link para outro recurso:
- www.scopus.com
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE Elsevier
Citações Recebidas na Web of Science: 13
Citações Recebidas na Scopus: 14
Documentos
- Não há documentos
Filiações
Keywords
- mHealth; ARIA; EAACI; Allergic rhinitis; Immunotherapy
Campos de estudo
Proyectos asociados
Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal (EPI-ASTHMA) - NCT05169619
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Observacional (EPI-ASTHMA) . AstraZeneca . 2021
Utilização em estudos observacionais do Registo de Asma Grave Portugal.
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Observacional Académico (RAG) . 2020
Use of secondary data, health technology assessment methods and economic modelling applied to penicillin allergy
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Using different data sources for the identification of asthma patients and those at high risk of adverse outcomes
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Phenotypes of Chronic Diseases of the Airways: Towards Multidimensional Data -Driven Profiling
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Citar a publicação
Bousquet J,Jutel M,Pfaar O,Fonseca J,Agache I,Czarlewski W,Bachert C,Bergmann KC,Cruz AA,Klimek L,Kvedariene V,Larenas DE,Papadopoulos NG,Patella V,Regateiro FS,Scichilone N,Shamji MH,Sheikh A,Valovirta E,Ventura MT,Zuberbier T. The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI Perspective. J. Allergy Clin. Immunol. Pract. 2021. 9(5):p. 1805-1812. IF:11,022. (1).
